Growth Equity

Propanc Biopharma is taking a 100-year-old cancer treatment concept into modern human trials, targeting advanced tumors and expanding into fibrosis.

As AI firm CluePoints expands globally, new CPO Sinead Godkin is tasked with scaling its human capital to match the pace of its technological innovation.

With a former mayor and Airbnb policy chief now in its C-suite, EverDriven signals a push to rewrite the rules for getting vulnerable students to school.

ETF firm TappAlpha soared from $100M to $250M in three months on its novel daily income ETFs. But what are the risks behind this explosive growth?

Amid an AI-driven capacity crunch, Bitzero partners with CBRE and Hydra Host to market its low-carbon Nordic data centers to hyperscalers and AI firms.

The investment firm celebrated a strong 2025 with shareholder payouts, fueled by profitable exits and a new major investment in AI infrastructure firm TensorWave.

Adimab's stellar 2025 reveals its crucial role as the hidden tech platform driving drug discovery for giants like Lilly and Regeneron.

The deal completes insitro’s TherML platform, integrating physics-informed AI to design better drugs faster by solving efficacy and manufacturing hurdles at once.

ProductPlan acquires AI-native Winware.ai, naming founder Steven Cohn its new CEO to forge an intelligence platform aimed at ending product uncertainty.

Biotech veteran Kamran Tavangar, who built a multi-billion dollar company at LabCentral, returns to lead its science strategy and shape the future of innovation.

With a hefty war chest and a veteran leadership team, Bleichroeder Acquisition Corp. II launches its search for a high-growth tech company to take public.

As its single-dose glaucoma therapy nears trials, Diorasis adds a seasoned dealmaker to its board, signaling a strategic shift toward market entry.

With 10,000+ registered, FastBull's free gold trading contest is a hit. But is it a path to real skill or a gamified pipeline for brokers?

With a key FDA decision looming, Orca Bio's massive new funding aims to commercialize a therapy that could make curative transplants safer for more patients.

Singapore's Temasek injects another $150M into Roc360's REIT, highlighting a major institutional shift to real estate debt to fix America's aging houses.

Pan Global Resources has defined a major copper and gold resource in Spain, fueling the green energy transition and reviving a historic mining district.

HiddenLayer joins a massive $151B defense contract to secure AI systems, signaling a new era where protecting AI is critical for national missile defense.

Enterprise veteran Stacey Epstein returns to her channel roots as CEO, launching a new AI platform to redefine partner marketing for giants like Google and IBM.

A new pact between AUMOVIO and AWS leverages generative AI to slash AV development time, with driverless trucks for Aurora first in line.

Amid a capacity crisis, a new model blending AI with human oversight gains traction, promising efficiency without sacrificing the crucial element of patient care.